ABEONA THERAPEUTICS INC. (ABEO) › Capital ExpendituresABEONA THERAPEUTICS INC. (ABEO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $7.0K2011: $40.0K2012: $13.0K2013: $2.0K2014: $02015: $308.0K2016: $519.0K2017: $860.0K2018: $9.24M2019: $6.31M2020: $1.34M2021: $4.15M2022: $130.0K2023: $331.0K2024: $2.45M2025: $7.97M$7.97M2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$7.97M+226.0%2024$2.45M+639.0%2023$331.0K+154.6%2022$130.0K-96.9%2021$4.15M+210.7%2020$1.34M-78.8%2019$6.31M-31.7%2018$9.24M+974.8%2017$860.0K+65.7%2016$519.0K+68.5%2015$308.0K—2014$0-100.0%2013$2.0K-84.6%2012$13.0K-67.5%2011$40.0K+471.4%2010$7.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share